These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25959998)

  • 41. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regenerative effect of basic fibroblast growth factor on periodontal healing in two-wall intrabony defects in dogs.
    Shirakata Y; Taniyama K; Yoshimoto T; Miyamoto M; Takeuchi N; Matsuyama T; Noguchi K
    J Clin Periodontol; 2010 Apr; 37(4):374-81. PubMed ID: 20447261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of bovine-derived xenografts and enamel matrix derivative in the treatment of intrabony periodontal defects in dogs.
    Yamamoto S; Masuda H; Shibukawa Y; Yamada S
    Int J Periodontics Restorative Dent; 2007 Oct; 27(5):471-9. PubMed ID: 17990444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Healing of two-wall intra-bony defects treated with a novel EMD-liquid-A pre-clinical study in monkeys.
    Shirakata Y; Miron RJ; Shinohara Y; Nakamura T; Sena K; Horai N; Bosshardt DD; Noguchi K; Sculean A
    J Clin Periodontol; 2017 Dec; 44(12):1264-1273. PubMed ID: 28965367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two infrabony defects.
    Froum S; Weinberg M; Novak J; Mailhot J; Mellonig J; Van Dyke T; McClain P; Papapanou PN; Childers G; Ciancio S; Blieden T; Polson A; Greenstein G; Yukna R; Wallace ML; Patters M; Wagener C
    J Periodontol; 2004 Jul; 75(7):1001-8. PubMed ID: 15341359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-rich plasma derived from bone marrow aspirate promotes new cementum formation.
    Nagata MJ; de Campos N; Messora MR; Santinoni CS; Bomfim SR; Fucini SE; Pola NM; Neves AP; de Almeida JM; Theodoro LH; Ervolino E
    J Periodontol; 2014 Dec; 85(12):1702-11. PubMed ID: 25102020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The application of an enamel matrix protein derivative (Emdogain) in regenerative periodontal therapy: a review.
    Sculean A; Schwarz F; Becker J; Brecx M
    Med Princ Pract; 2007; 16(3):167-80. PubMed ID: 17409750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of enamel matrix derivative with freeze-dried bone allograft or demineralized freeze-dried bone allograft in intrabony defects: a randomized trial.
    Ogihara S; Tarnow DP
    J Periodontol; 2014 Oct; 85(10):1351-60. PubMed ID: 24660759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the capacity of enamel matrix derivative gel and enamel matrix derivative in liquid formulation to adsorb to bone grafting materials.
    Miron RJ; Bosshardt DD; Buser D; Zhang Y; Tugulu S; Gemperli A; Dard M; Caluseru OM; Chandad F; Sculean A
    J Periodontol; 2015 Apr; 86(4):578-87. PubMed ID: 25594536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experimental study of periodontal tissue regeneration after the application of enamel matrix derivative in rat periodontal defects].
    Kikuchi S
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):82-92. PubMed ID: 11321810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: secondary outcomes.
    Meyle J; Gonzales JR; Bödeker RH; Hoffmann T; Richter S; Heinz B; Arjomand M; Reich E; Sculean A; Jepsen K; Jepsen S
    J Periodontol; 2004 Sep; 75(9):1188-95. PubMed ID: 15515332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The use of Emdogain in periodontal and osseous regeneration].
    Sculean A; Rathe F; Junker R; Becker J; Schwarz F; Arweiler N
    Schweiz Monatsschr Zahnmed; 2007; 117(6):598-606. PubMed ID: 17691421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of the enamel matrix derivative to induce cementogenesis in vital and endodontically treated teeth with osseous dehiscence defects.
    Al-Hezaimi K; Naghshbandi J; Al-Rasheed A; Merdad K; Simon JH; Rotstein I
    Dent Traumatol; 2011 Oct; 27(5):350-5. PubMed ID: 21722307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presence of an enamel matrix protein derivative on human teeth following periodontal surgery.
    Sculean A; Windisch P; Keglevich T; Fabi B; Lundgren E; Lyngstadaas PS
    Clin Oral Investig; 2002 Sep; 6(3):183-7. PubMed ID: 12271353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
    Sculean A; Windisch P; Keglevich T; Gera I
    Int J Periodontics Restorative Dent; 2005 Apr; 25(2):139-47. PubMed ID: 15839590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.